Video: What are the risks of Age-Related Macular Degeneration treatment?
In this video I am explaining the possible risks of Age-Related Macular Degeneration (AMD) treatment.
Age-Related Macular Degeneration treatment is a safe treatment; the idea of having an injection in the back of the eye doesn’t sit very well with most people and I spend a lot of time with my private patients discussing that treatment and we are reassuring them that it actually is not as bad as it sounds.
It’s not painful and the risks involved are very very small and because the injections is a very very fine needle there is very, very little risk involved.
The one risk we worry about is an infection inside the eye but thankfully we have good sterilisation techniques and good surgical hands and good experience, which I obviously have, the risk of having an infection is probably one in two and half thousand.
Now the advantage of having private health care and being treated privately is if you were to ever develop that risk you’d be seen straight away. I would review you very quickly to ensure that this risk didn’t develop into a long term problem.
Now I don’t want to shy away from the issue of the risk, but as I say that it’s very minimal and I don’t think you need to worry too much about it.
We can give you the leaflet on Age-Related Macular Degeneration and its treatments and discuss it in further details.
If you’d like to do that you can ring my number at the end of the video and we can discuss that in detail.
About Jaheed Khan
My name is Jaheed Khan and I am a Consultant Eye Surgeon at Moorfields Eye Hospital and Clinica London.
My special expertise is in cataract surgery and conditions affecting the back of the eye, the retina, including AMD (Age Related Macular Degeneration), diabetic retinopathy, and various other diseases of the retina.
I have over 15 years experience in treating people with eye problems just like you, and have published extensively in scientific journals about treating eye conditions.
In my NHS practice, I am responsible day-to-day for the training of the eye surgeons of the future.